| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.5M | — | -16.0% |
| Cost of Revenue | $4.9M | — | -20.2% |
| Gross Profit | $15.6M | — | -14.6% |
| R&D Expense | $1.8M | — | -22.1% |
| SG&A Expense | $11.6M | — | +6.3% |
| Operating Income | -$633K | — | -183.1% |
| Pre-tax Income | -$470K | — | -169.8% |
| Income Tax | -$10K | — | -117.9% |
| Net Income | -$460K | — | -174.6% |
| EPS (Basic) | $0.00 | — | -100.0% |
| EPS (Diluted) | $0.00 | — | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $173.3M | -1.9% | -26.6% |
| Accounts Receivable | $4.8M | +30.1% | -14.3% |
| Current Assets | $218.1M | -2.0% | -21.5% |
| Total Assets | $231.1M | -2.4% | -24.0% |
| Current Liabilities | $49.1M | -0.2% | +9.9% |
| Long-term Debt | $82.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$764K | — | +80.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$289K | — | +52.3% |
| Financing Cash Flow | -$2.2M | — | +15.9% |
| Free Cash Flow | -$764K | — | +80.3% |
| -39.9% |
| Total Liabilities | $155.8M | -3.7% | -30.6% |
| Stockholders' Equity | $75.3M | +0.5% | -5.7% |